Use of topical benzydamine in gynecology

G. Bentivoglio, F. Diani

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

To evaluate the topical anti-inflammatory activity of benzydamine when used as 0.1% solution for vaginal douche, a double blind, parallel group, randomized clinical trial was carried out on 30 patients with vaginitis following internal radiotherapy for carcinoma of the uterus. The patients were divided into 3 groups, one being treated with 0.1% benzydamine plus tricetol as preservative, one with 0.1% benzydamine alone, and one with placebo. Treatment began 12-24 hours after radiotherapy. Benzydamine was found to be significantly superior to placebo in its overall topical anti-inflammatory activity both ater 5 and 15 days of treatment. Tricetol did not interfere with the therapeutic effect of benzydamine.

Original languageEnglish
Pages (from-to)103-110
Number of pages8
JournalClinical and Experimental Obstetrics and Gynecology
Volume8
Issue number3
Publication statusPublished - 1981

Fingerprint

Benzydamine
Gynecology
Anti-Inflammatory Agents
Radiotherapy
Placebos
Vaginitis
Therapeutic Uses
Uterus
Randomized Controlled Trials
Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Use of topical benzydamine in gynecology. / Bentivoglio, G.; Diani, F.

In: Clinical and Experimental Obstetrics and Gynecology, Vol. 8, No. 3, 1981, p. 103-110.

Research output: Contribution to journalArticle

Bentivoglio, G & Diani, F 1981, 'Use of topical benzydamine in gynecology', Clinical and Experimental Obstetrics and Gynecology, vol. 8, no. 3, pp. 103-110.
Bentivoglio, G. ; Diani, F. / Use of topical benzydamine in gynecology. In: Clinical and Experimental Obstetrics and Gynecology. 1981 ; Vol. 8, No. 3. pp. 103-110.
@article{df11e74b3e984b159102c28d21516648,
title = "Use of topical benzydamine in gynecology",
abstract = "To evaluate the topical anti-inflammatory activity of benzydamine when used as 0.1{\%} solution for vaginal douche, a double blind, parallel group, randomized clinical trial was carried out on 30 patients with vaginitis following internal radiotherapy for carcinoma of the uterus. The patients were divided into 3 groups, one being treated with 0.1{\%} benzydamine plus tricetol as preservative, one with 0.1{\%} benzydamine alone, and one with placebo. Treatment began 12-24 hours after radiotherapy. Benzydamine was found to be significantly superior to placebo in its overall topical anti-inflammatory activity both ater 5 and 15 days of treatment. Tricetol did not interfere with the therapeutic effect of benzydamine.",
author = "G. Bentivoglio and F. Diani",
year = "1981",
language = "English",
volume = "8",
pages = "103--110",
journal = "Clinical and Experimental Obstetrics and Gynecology",
issn = "0390-6663",
publisher = "S.O.G. CANADA Inc.",
number = "3",

}

TY - JOUR

T1 - Use of topical benzydamine in gynecology

AU - Bentivoglio, G.

AU - Diani, F.

PY - 1981

Y1 - 1981

N2 - To evaluate the topical anti-inflammatory activity of benzydamine when used as 0.1% solution for vaginal douche, a double blind, parallel group, randomized clinical trial was carried out on 30 patients with vaginitis following internal radiotherapy for carcinoma of the uterus. The patients were divided into 3 groups, one being treated with 0.1% benzydamine plus tricetol as preservative, one with 0.1% benzydamine alone, and one with placebo. Treatment began 12-24 hours after radiotherapy. Benzydamine was found to be significantly superior to placebo in its overall topical anti-inflammatory activity both ater 5 and 15 days of treatment. Tricetol did not interfere with the therapeutic effect of benzydamine.

AB - To evaluate the topical anti-inflammatory activity of benzydamine when used as 0.1% solution for vaginal douche, a double blind, parallel group, randomized clinical trial was carried out on 30 patients with vaginitis following internal radiotherapy for carcinoma of the uterus. The patients were divided into 3 groups, one being treated with 0.1% benzydamine plus tricetol as preservative, one with 0.1% benzydamine alone, and one with placebo. Treatment began 12-24 hours after radiotherapy. Benzydamine was found to be significantly superior to placebo in its overall topical anti-inflammatory activity both ater 5 and 15 days of treatment. Tricetol did not interfere with the therapeutic effect of benzydamine.

UR - http://www.scopus.com/inward/record.url?scp=0019770305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019770305&partnerID=8YFLogxK

M3 - Article

C2 - 7042126

AN - SCOPUS:0019770305

VL - 8

SP - 103

EP - 110

JO - Clinical and Experimental Obstetrics and Gynecology

JF - Clinical and Experimental Obstetrics and Gynecology

SN - 0390-6663

IS - 3

ER -